A novel nanoformulation to cure deadly brain tumours has shown promise in pre-clinical trials, researchers at the Indian Institute of Technology (IIT) Delhi said on Thursday. 

Glioblastoma, the most common and aggressive type of cancerous brain tumour in adults, poses significant treatment challenges despite available options like surgery, radiation, and chemotherapy.